Suchergebnisse - "Li, Lanjuan"

PubPharm (113)

1

Patient-derived mutations impact pathogenicity of SARS-CoV-2

enthalten in: bioRxiv.org | 2024

von Yao, H. | Lu, X. | Chen, Q. | +11

2

Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China : a multicentre, double-blind, phase 3, randomised controlled study

enthalten in: The Lancet. Infectious diseases | 2024

von Fan, X. | Dai, X. | Ling, Y. | +36

3

Human type 5 replication-deficient recombinant adenovirus based on target gene S1, preparation method and vaccine for preventing SARS-CoV-2 infection

enthalten in: Europäisches Patentamt | 2023

von LI LANJUAN | CHEN KEDA | YAO HANGPING | +3

4

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19 : A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults

enthalten in: Infectious diseases and therapy | 2023

von Chen, G. | Li, N. | Dai, X. | +10

5

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults

enthalten in: Infectious diseases and therapy | 2023

von Chen, G. | Li, N. | Dai, X. | +10

6

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults

enthalten in: Infectious diseases and therapy | 2023

von Chen, G. | Li, N. | Dai, X. | +10

7

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Anti-C5a Antibody BDB-001 for Severe COVID-19: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Clinical Trial in Healthy Chinese Adults

enthalten in: Infectious diseases and therapy | 2023

von Chen, G. | Li, N. | Dai, X. | +10

8

Corona virus disease 2019-associated liver injury in cold regions

enthalten in: Frigid zone medicine | 2022

von Tang, S. | Zhang, F. | Liu, Q. | +1

9

Temporal Contact Graph Reveals the Evolving Epidemic Situation of COVID-19

enthalten in: ResearchSquare.com | 2022

von Wu, M. | Li, C. | Shen, Z. | +16

10

Temporal Contact Graph Reveals The Evolving Epidemic Situation of COVID-19

enthalten in: ResearchSquare.com | 2022

von Wu, M. | Li, C. | Shen, Z. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]